Korea Stocks, page 6 of 36 — 24 articles published 2026-09-09 ~ 2026-09-12.
Kolon Life Sciences (KOSDAQ 102940) 2026 outlook: the API/CDMO cash business, the KLS-2031 gene-therapy pipeline, the unresolved Invossa litigation overhang, and how a US-based investor should size and access this small-cap Korean name.
Kwangju Shinsegae (037710) 2026 stock outlook: near-monopoly in Korea's Honam department store market, Shinsegae brand-royalty ties, chronic low-PBR valuation, and governance catalysts to watch.
Manho Rope & Wire (KRX: 001080) 2026 stock outlook: the wire rope business behind shipbuilding, construction and cranes, the wire-rod cost spread, the low-PBR asset case, thin liquidity, and Value-up re-rating triggers.
Yellow Balloon Tour (104620) stock outlook 2026: how this direct-sales Korean travel agency is positioned as outbound demand normalizes, and how it stacks up against Hana Tour and Mode Tour on margin and share.
A 2026 stock outlook for Wemade Play (formerly Sunday Toz, KRX 123420), covering the Anipang franchise cash flow, social casino overseas growth, Wemade group synergy, and new-title pipeline versus churn risk.
Komipharm (041960) stock outlook 2026: a qualitative look at its veterinary vaccine cash flow, unapproved PAX-1 oncology pipeline, clinical-event risk, and the valuation gap common to Korean micro-cap biotech stocks.
Chokwang Paint (KRX:004910) 2026 stock outlook. We break down its architectural and industrial coatings business, the resin-and-solvent cost-versus-price spread that drives margins, its early-stage electronics and battery-adjacent specialty coating ambitions, and the valuation and liquidity risks specific to a Korean small-cap chemical name.
SNT Energy (formerly S&TC, KRX 100840) stock outlook 2026: a qualitative read on its Middle East air-cooled heat exchanger business, HRSG and SCR growth bets, order backlog cyclicality, and currency risk.
Asia Paper Mfg (KRX: 002310) stock outlook 2026: how Korean e-commerce parcel volume drives corrugated box demand, the waste-paper (OCC) spread that decides margins, the group's linerboard-to-box vertical integration, low price-to-book value-up program upside, dividend appeal, and risks for foreign investors accessing Korean small caps.
Lotte REIT (330590) 2026 stock outlook for global investors. A qualitative look at its master-lease structure with Lotte Shopping, sponsor-credit concentration risk, rate-cut sensitivity, LTV discipline and acquisition growth, benchmarked against US net-lease and retail REITs like Realty Income, VICI, and Simon Property Group.
DL Construction (KRX: 001880) stock outlook for 2026, covering the DL Group ownership structure, Korea's housing-cycle bottom debate, project-financing guarantee exposure, small-cap builder re-rating potential, and how a foreign investor can actually access this KRX small-cap.
A 2026 outlook on Daebong LS (078140), the Korean amino-acid API maker whose fermentation and synthesis know-how feeds both pharmaceutical manufacturers and, through Jeju-sourced natural ingredients, the K-beauty supply chain, covering its in-house clinical testing subsidiary, global GMP path, and risks.
A qualitative 2026 outlook for Dongbang (KRX: 004140), a Busan-based integrated logistics company spanning port stevedoring, land and sea transport, third-party logistics, container terminal operation, and distribution centers. We cover its entry-barrier moat, its low-PBR asset-stock thesis tied to port land holdings, cargo-volume and freight-rate cycle risk, and how international investors can frame ownership.
PKC Corp, formerly Paik Kwang Industrial (KRX 001340), 2026 stock outlook: how its caustic soda and specialty gas cash flow funds a new push into battery and semiconductor materials, the moat behind each segment, capital allocation trade-offs, and risks for foreign investors accessing Korean small caps.
DB Securities (016610, formerly DB Financial Investment) stock outlook 2026: how this mid-tier Korean broker built its edge in bond trading and structured-finance IB, why retail brokerage remains a weak spot, how real estate project-financing exposure shapes the risk case, and a peer comparison table for international investors.
SeAH Special Steel (KRX 019440) 2026 stock outlook: the cold-heading quality (CHQ) wire rod and precision bar materials business, the AT division making automotive steering rack bars, the 2024 SeAH Metal merger that scaled up capacity, and the auto-cycle and raw-material-spread risks investors should weigh.
Mobirix (348030) stock outlook 2026: a KOSDAQ mobile game publisher running 300-plus casual and mid-core titles on a hybrid-casual ad-plus-IAP model. We cover the low hit-dependency thesis, mobile ad ecosystem risk, a peer comparison table, and a practical playbook for non-Korean investors including access and tax basics.
Boditech Med (206640) stock outlook 2026. A deep, qualitative look at the razor-and-blade model behind this Korean point-of-care diagnostics maker: reader placement versus recurring cartridge sales, its 130-country distribution moat, post-COVID base-effect risk, currency exposure, and a peer comparison.
HIMS (KOSDAQ 238490) stock outlook for 2026, covering its near-monopoly position in fine metal mask tensioning equipment for mobile OLED deposition, the foldable and IT OLED expansion that could drive its next order cycle, and the Samsung Display concentration risk that cuts both ways for this niche Korean equipment maker.
SFA Nexel (formerly CIS, ticker 222080) stock outlook 2026. We break down its electrode coating and calendering equipment moat, what joining the SFA Group actually changed in capital access and order backlog, and why the EV demand chasm is the biggest swing factor for this Korean battery equipment stock.
Neosem (253590) stock outlook 2026: a qualitative deep dive into how Advantest's retreat from SSD test equipment opened the door for Gen5/Gen6 dominance, why CXL memory testers matter for the AI datacenter storage cycle, customer concentration risk, and how a foreign investor can actually access this KOSDAQ name.
JC Chemical (KOSDAQ 137950) stock outlook 2026: how this Korean biodiesel and bio-heavy-oil supplier to SK, GS Caltex and Hyundai Oilbank uses its own Indonesian palm oil plantations to hedge feedstock costs, and what the mandatory blending mandate plus SAF demand could mean for the stock.
Orbitech (KOSDAQ 046120) stock outlook 2026: nondestructive testing and nuclear plant maintenance paired with aircraft parts manufacturing, plus the access, tax, and FX questions US investors face buying this Korean small-cap.
DK-Lok Corporation (KRX: 105740) stock outlook 2026: how this KOSDAQ-listed instrumentation fittings and valve maker is displacing Swagelok and Parker imports across shipbuilding, refining, semiconductor, and hydrogen infrastructure, plus the FX and order-cycle risks.